Event

Hot Topic Discussion: Join FDA's Dr. Peter Marks for an Individual Donor Assessment Update (23EL-840) – Free for everyone!

Please note: AABB reserves the right to make updates to this program.

Live Program Date: Thursday, May 25, 2023 – On-Demand Available
Program Number: 23EL-840

Registration

This on-demand program is complimentary to all, but registration is required. After signing up on GoToWebinar, the video will immediately begin to play.

  • Program Description

    Join a discussion with Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER), about the recently released final guidance that recommends the adoption of individual donor assessment (IDA) to determine blood donor eligibility. Following Marks’ presentation, Sharon Carayiannis, AABB Vice President of Science and Practice, will moderate a question-and-answer period.

    Faculty

    • Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration
    • Anne Eder, MD, PhD, Deputy Director, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
    • Sharon Carayiannis, BSMT(ASCP)HP, Vice President, Science and Practice, AABB

    Continuing Education Credit

    Continuing education credit will not be offered for this program.

    Register